Cite

HARVARD Citation

    Kessler, L. et al. (2015). A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden. Acta oncologica. pp. 522-529. [Online]. 
  
Back to record